{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:24:06Z","timestamp":1784870646145,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003186","name":"Fredrik and Ingrid Thurings Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jad.2026.122033","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:23:56Z","timestamp":1780118636000},"page":"122033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pramipexole exposure and risk of incident gambling disorder in individuals with psychiatric disorders: A nationwide register-based cohort study"],"prefix":"10.1016","volume":"412","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-1887","authenticated-orcid":false,"given":"S.","family":"Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wolfschlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2026.122033_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cen.12375","article-title":"Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study","volume":"80","author":"Bancos","year":"2014","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21556660.2019.1675670","article-title":"Risk factors for impulse control disorders and related behaviors in Parkinson\u2019s disease: secondary analyses of the ICARUS study","volume":"8","author":"Barone","year":"2019","journal-title":"J. Drug Assess."},{"issue":"12","key":"10.1016\/j.jad.2026.122033_bb0015","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1111\/add.15952","article-title":"Global prevalence of help-seeking for problem gambling: a systematic review and meta-analysis","volume":"117","author":"Bijker","year":"2022","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.jad.2026.122033_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2215-0366(25)00194-4","article-title":"Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK","volume":"12","author":"Browning","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.122033_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40263-024-01087-y","article-title":"Impulse control disorders in Parkinson\u2019s disease: an overview of risk factors, pathogenesis and pharmacological management","volume":"38","author":"Carbone","year":"2024","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0030","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H","article-title":"Comparison of pramipexole, fluoxetine, and placebo in patients with major depression","volume":"11","author":"Corrigan","year":"2000","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0040","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jad.2026.122033_bb0045","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.4088\/JCP.12m08093","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder","volume":"74","author":"Cusin","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WNF.0b013e31820d6699","article-title":"The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome","volume":"34","author":"Dang","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mds.29700","article-title":"Management of impulse control and related disorders in Parkinson\u2019s disease: an expert consensus","volume":"39","author":"Debove","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2026.122033_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2014.06.023","article-title":"Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment","volume":"167","author":"Di Nicola","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2026.122033_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/wnf.0b013e31804c780e","article-title":"Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome","volume":"30","author":"Driver-Dunckley","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10899-022-10119-5","article-title":"The association between the five-factor model of personality and problem gambling: a meta-analysis","volume":"39","author":"Dudfield","year":"2023","journal-title":"J. Gambl. Stud."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","article-title":"Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study","volume":"37","author":"Etminan","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2013.02.018","article-title":"High-risk behaviour in hypomanic states","volume":"150","author":"Fletcher","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","article-title":"Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression","volume":"161","author":"Goldberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","volume":"41","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.jad.2026.122033_bb0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2147\/PRBM.S226982","article-title":"The general population\u2019s view on where to seek treatment for gambling disorder - a general population survey","volume":"12","author":"H\u00e5kansson","year":"2019","journal-title":"Psychol. Res. Behav. Manag."},{"key":"10.1016\/j.jad.2026.122033_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1293887","article-title":"Treatment seeking for gambling disorder in nationwide register data - observations around a major shift in legislation","volume":"12","author":"H\u00e5kansson","year":"2024","journal-title":"Front. Public Health"},{"issue":"9","key":"10.1016\/j.jad.2026.122033_bb0105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.5664\/jcsm.7908","article-title":"Increased risk for new-onset psychiatric adverse events in patients with newly diagnosed primary restless legs syndrome who initiate treatment with dopamine agonists: a large-scale retrospective claims matched-cohort analysis","volume":"15","author":"Hankin","year":"2019","journal-title":"J. Clin. Sleep Med."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1212\/WNL.0000000000002803","article-title":"Augmentation and impulsive behaviors in restless legs syndrome: coexistence or association?","volume":"87","author":"Heim","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/acn3.535","article-title":"Reflection impulsivity perceptual decision-making in patients with restless legs syndrome","volume":"5","author":"Heim","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40801-015-0028-3","article-title":"Dopamine agonists: time pattern of adverse effects reporting in Australia","volume":"2","author":"Hollingworth","year":"2015","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10899-009-9123-2","article-title":"Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia","volume":"25","author":"Holman","year":"2009","journal-title":"J. Gambl. Stud."},{"issue":"4","key":"10.1016\/j.jad.2026.122033_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1192\/bjp.bp.114.154286","article-title":"Gambling problems in bipolar disorder in the UK: prevalence and distribution","volume":"207","author":"Jones","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2005.12.040","article-title":"Pathological gambling and mood disorders: clinical associations and treatment implications","volume":"92","author":"Kim","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122033_bb0140","article-title":"Association between gambling disorder and suicide mortality: a comparative cohort study using Norwegian health registry data","volume":"48","author":"Kristensen","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12889-016-2747-0","article-title":"Understanding gambling related harm: a proposed definition, conceptual framework, and taxonomy of harms","volume":"16","author":"Langham","year":"2016","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.jad.2026.122033_bb0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.sleep.2012.08.004","article-title":"Long-term use of pramipexole in the management of restless legs syndrome","volume":"13","author":"Lipford","year":"2012","journal-title":"Sleep Med."},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1360-0443.2010.03300.x","article-title":"Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys","volume":"106","author":"Lorains","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2026.122033_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106378","article-title":"Emotion regulation interacts with gambling motives to predict problem gambling among emerging adults","volume":"106","author":"Marchica","year":"2020","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2026.122033_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.980303","article-title":"Gambling-related suicides and suicidality: a systematic review of qualitative evidence","volume":"13","author":"Marionneau","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"21","key":"10.1016\/j.jad.2026.122033_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/HBFC1953","article-title":"Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial","volume":"29","author":"McAllister-Williams","year":"2025","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.jad.2026.122033_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","article-title":"Predictors of impulsivity and reward seeking behavior with dopamine agonists","volume":"14","author":"Ondo","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1\u20132","key":"10.1016\/j.jad.2026.122033_bb0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2009.11.010","article-title":"Compulsive habits in restless legs syndrome patients under dopaminergic treatment","volume":"290","author":"Pourcher","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2026.122033_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/appi.ajp.163.2.297","article-title":"Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys","volume":"163","author":"Slutske Wendy","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.122033_bb0190","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10072-023-07254-1","article-title":"Impulse control disorders in Parkinson\u2019s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis","volume":"45","author":"Soileau","year":"2024","journal-title":"Neurol. Sci."},{"issue":"2021","key":"10.1016\/j.jad.2026.122033_bb0195","article-title":"The relationship between gambling problems and the five-factor model of personality: a systematic review and meta-analysis [systematic review]","volume":"12","author":"Str\u00f8mme","year":"2021","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb0200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/acps.13055","article-title":"Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis","volume":"140","author":"Tundo","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122033_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110425","article-title":"Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study","volume":"112","author":"Tundo","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.122033_bb0210","article-title":"Pramipexole augmentation for treatment-resistant unipolar and bipolar depression in the real world: a systematic review and meta-analysis","volume":"13","author":"Tundo","year":"2023","journal-title":"Life (Basel)"},{"issue":"9","key":"10.1016\/j.jad.2026.122033_bb0215","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3390\/biomedicines12092064","article-title":"Comparative short- and long-term effectiveness and safety of pramipexole and aripiprazole augmentation in treatment-resistant unipolar depression: an observational study","volume":"12","author":"Tundo","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jad.2026.122033_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1404904","article-title":"Impulse control disorders and use of dopamine agonists in early onset Parkinson\u2019s disease","volume":"15","author":"Turcano","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jad.2026.122033_bb0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2377-11-117","article-title":"Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome","volume":"11","author":"Voon","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jad.2026.122033_bb0230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpsychires.2025.10.067","article-title":"Gambling disorder and suicide risk: a meta-epidemiology study","volume":"192","author":"Wang","year":"2026","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122033_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120087","article-title":"Efficacy and tolerability of pramipexole versus antidepressants for Parkinson\u2019s disease with depression: a meta-analysis of randomized controlled trials","volume":"392","author":"Wei","year":"2026","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2026.122033_bb9000","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jad.2026.122033_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2024-334116","article-title":"Impulse control disorders in Parkinson\u2019s disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups","volume":"96","author":"Wolfschlag","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2026.122033_bb0245","first-page":"1","article-title":"Clinical aspects of impulsive-compulsive behaviors under dopaminergic treatment-a scoping review","author":"Wolfschlag","year":"2026","journal-title":"Australas. Psychiatry."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726008852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726008852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:07:59Z","timestamp":1784578079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726008852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0165032726008852"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122033","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pramipexole exposure and risk of incident gambling disorder in individuals with psychiatric disorders: A nationwide register-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122033"}}